AnaptysBio Announces Second Quarter 2021 Financial Results and Provides Pipeline Updates

NEXT STORY
IGM Biosciences Announces Second Quarter 2021 Financial Results and Provides Corporate Update
PREV STORY
Eldorado Gold Announces Launch of US$500 Million Senior Notes Offering
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Adverum Announces Senior Appointments for Patient Access and Clinical Operations as ADVM-022 Advances Toward Global Phase 3 Trials

author_avatar
NASDAQ Market News

Zealand Pharma convenes its Annual General Meeting 2019

author_avatar
NASDAQ Market News

Athenex Announces Additional Licensing Agreements for Tirbanibulin

author_avatar
NASDAQ Market News